Most Recent
CBA has attacked two failed class actions' "misguided" appeal, arguing that requiring companies to disclose incomplete information to shareholders would distort the market.
Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
A judge on Friday rejected Latitude Finance's defence in ASIC's case over Harvey Norman's 'interest-free' ads that no reasonable consumer would expect “a charitable free lunch”.
Applicants in two dismissed class actions against the Commonwealth Bank have secured an order staying an assessment of costs in the failed cases until the outcome of an appeal.
Two failed shareholder class actions against the Commonwealth Bank of Australia want to delay paying the bank's costs until after their 62-ground appeal is heard.
Over objections from the ACCC, a judge has struck out the regulator's entire case against Meta over scam cryptocurrency ads on Facebook after it clarified that each allegedly misleading ad should be a separate contravention.
Hyundai and Kia have been ordered to produce further documents to allow a class action to investigate the nature and extent of alleged engine defects, with a judge rejecting the car makers’ bid to produce only a sample set of documents.
A three-day penalty hearing in action against payday lenders BSF Solutions and Cigno -- in which ASIC is seeking a multi-million dollar fine -- has been put on ice until after a challenge to a finding that they were unlicensed credit providers.
The consumer regulator must identify the advertisements it relies on to prove its case against Meta over scam cryptocurrency ads on Facebook, with a judge saying the social media giant should know the case it has to meet.